False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma

Nijhuis, AAG; Dieng, M; Khanna, N; Lord, SJ; Dalton, J; Menzies, AM; Turner, RM; Allen, J; Saw, RPM; Nieweg, OE; Thompson, JF; Morton, RL

False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma

Nijhuis, AAG Dieng, M Khanna, N

Lord, SJ Dalton, J Menzies, AM Turner, RM Allen, J Saw, RPM Nieweg, OE Thompson, JF Morton, RL

Permalink

Publisher:: SPRINGER
Publication Type:: Journal Article
Citation:: Annals of Surgical Oncology, 2019, 26, (6), pp. 1860-1868
Issue Date:: 2019-06-01

Closed Access

	Filename	Description	Size
	Nijhuis2019_Article_False-PositiveResultsAndIncide.pdf	Published version	360.33 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Nijhuis, AAG
dc.contributor.author	Dieng, M
dc.contributor.author	Khanna, N https://orcid.org/0000-0002-4052-3610
dc.contributor.author	Lord, SJ
dc.contributor.author	Dalton, J
dc.contributor.author	Menzies, AM
dc.contributor.author	Turner, RM
dc.contributor.author	Allen, J
dc.contributor.author	Saw, RPM
dc.contributor.author	Nieweg, OE
dc.contributor.author	Thompson, JF
dc.contributor.author	Morton, RL
dc.date.accessioned	2020-05-18T04:18:39Z
dc.date.available	2020-05-18T04:18:39Z
dc.date.issued	2019-06-01
dc.identifier.citation	Annals of Surgical Oncology, 2019, 26, (6), pp. 1860-1868
dc.identifier.issn	1068-9265
dc.identifier.issn	1534-4681
dc.identifier.uri	http://hdl.handle.net/10453/140776
dc.description.abstract	The aim of this study was to quantify false-positive and incidental findings from annual surveillance imaging in asymptomatic, American Joint Committee on Cancer stage III melanoma patients.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	SPRINGER
dc.relation.ispartof	Annals of Surgical Oncology
dc.relation.isbasedon	10.1245/s10434-019-07311-0
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	1112 Oncology and Carcinogenesis
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.mesh	Humans
dc.subject.mesh	Melanoma
dc.subject.mesh	Neoplasm Recurrence, Local
dc.subject.mesh	Radiopharmaceuticals
dc.subject.mesh	False Positive Reactions
dc.subject.mesh	Neoplasm Staging
dc.subject.mesh	Incidental Findings
dc.subject.mesh	Follow-Up Studies
dc.subject.mesh	Prospective Studies
dc.subject.mesh	Middle Aged
dc.subject.mesh	Female
dc.subject.mesh	Male
dc.subject.mesh	Positron Emission Tomography Computed Tomography
dc.subject.mesh	False Positive Reactions
dc.subject.mesh	Female
dc.subject.mesh	Follow-Up Studies
dc.subject.mesh	Humans
dc.subject.mesh	Incidental Findings
dc.subject.mesh	Male
dc.subject.mesh	Melanoma
dc.subject.mesh	Middle Aged
dc.subject.mesh	Neoplasm Recurrence, Local
dc.subject.mesh	Neoplasm Staging
dc.subject.mesh	Positron Emission Tomography Computed Tomography
dc.subject.mesh	Prospective Studies
dc.subject.mesh	Radiopharmaceuticals
dc.title	False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma
dc.type	Journal Article
utslib.citation.volume	26
utslib.location.activity	United States
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2020-05-18T04:18:35Z
pubs.issue	6
pubs.publication-status	Published
pubs.volume	26
utslib.start-page	1860
utslib.citation.issue	6

Abstract:

The aim of this study was to quantify false-positive and incidental findings from annual surveillance imaging in asymptomatic, American Joint Committee on Cancer stage III melanoma patients.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/140776